Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
303
-
Total 13F shares, excl. options
-
52.2M
-
Shares change
-
-14M
-
Total reported value, excl. options
-
$4.62B
-
Value change
-
-$1.25B
-
Put/Call ratio
-
0.89
-
Number of buys
-
143
-
Number of sells
-
-157
-
Price
-
$88.49
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2014
354 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2014.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 303 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.2M shares
.
Largest 10 shareholders include FMR LLC (4.5M shares), VANGUARD GROUP INC (2.83M shares), DEUTSCHE BANK AG\ (2.18M shares), AJO, LP (2.06M shares), BlackRock Fund Advisors (1.92M shares), LSV ASSET MANAGEMENT (1.9M shares), ACADIAN ASSET MANAGEMENT LLC (1.88M shares), BlackRock Institutional Trust Company, N.A. (1.71M shares), State Street Corp (1.38M shares), and TimesSquare Capital Management, LLC (1.31M shares).
This table shows the top 303 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.